10-Q/A Filing

GLUCOSE HEALTH, INC. CIK: 1420108 Q2 2012

Filing Information

Form Type	10-Q/A
Accession Number	`0001432093-12-000689`
Period End Date	20120630
Filing Date	20120831
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	bisu-20120630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 51 Income Statement 80 Cash Flow Statement 46

Balance Sheet 51 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$220.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$82.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	75.00M	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$27.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$27.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	65.44M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	67.19M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$27.22K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	65.44M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$27.08K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	67.19M	shares	Point-in-time
Intellectual property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
Intellectual property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$233.68K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$233.82K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$296.43K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$130.78K	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	-	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	$41.50K	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	-	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	$19.67K	USD	Point-in-time
Short - term loans - related party	`NotesPayableRelatedPartiesClassifiedCurrent`	$49.16K	USD	Point-in-time
Short - term loans - related party	`NotesPayableRelatedPartiesClassifiedCurrent`	$1.56K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$47.15K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$8.20K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	-	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$4.75K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$179.49K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$419.70K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$179.49K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$419.70K	USD	Point-in-time
Common stock, $0.001 par value, 90,000,000 shares authorized, 67,190,397 and 65,440,397 shares issued and outstanding as of June 30, 2012 and December 31, 2010, respectively	`CommonStockValue`	$65.44K	USD	Point-in-time
Common stock, $0.001 par value, 90,000,000 shares authorized, 67,190,397 and 65,440,397 shares issued and outstanding as of June 30, 2012 and December 31, 2010, respectively	`CommonStockValue`	$67.19K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$2.86M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$3.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$361.88K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$169.57K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-69.16K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-69.22K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-186.02K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$54.33K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$233.82K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$233.68K	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	-	USD	2 Qtrs
REVENUE	`SalesRevenueGoodsNet`	-	USD	2 Qtrs
REVENUE	`SalesRevenueGoodsNet`	-	USD	1 Quarter
REVENUE	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Beginning inventory	`InventoryFinishedGoods`	$87.76K	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	$89.82K	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	$-90.52K	USD	Point-in-time
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	1 Quarter
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	2 Qtrs
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	1 Quarter
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	2 Qtrs
Ending inventory	`InventoryFinishedGoods`	$87.76K	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	$89.82K	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	$-90.52K	USD	Point-in-time
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	2 Qtrs
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	1 Quarter
Total Cost of Revenues	`CostOfGoodsSold`	$-698.00	USD	1 Quarter
Total Cost of Revenues	`CostOfGoodsSold`	$-2.76K	USD	2 Qtrs
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	1 Quarter
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	2 Qtrs
GROSS PROFIT (LOSS)	`GrossProfit`	$2.76K	USD	2 Qtrs
GROSS PROFIT (LOSS)	`GrossProfit`	$698.00	USD	1 Quarter
Professional fees and wages	`SalariesAndWages`	$18.09K	USD	1 Quarter
Professional fees and wages	`SalariesAndWages`	$550.27K	USD	2 Qtrs
Professional fees and wages	`SalariesAndWages`	$23.77K	USD	2 Qtrs
Professional fees and wages	`SalariesAndWages`	$448.89K	USD	1 Quarter
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	2 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	1 Quarter
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	2 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$9.82K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.76K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.49K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.19K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$28.25K	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$560.10K	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$453.65K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$21.27K	USD	1 Quarter
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-21.27K	USD	1 Quarter
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-28.25K	USD	2 Qtrs
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-557.34K	USD	2 Qtrs
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-452.95K	USD	1 Quarter
Interest expense	`InterestExpense`	$5.34K	USD	1 Quarter
Interest expense	`InterestExpense`	$10.54K	USD	2 Qtrs
Interest expense	`InterestExpense`	$164.06K	USD	2 Qtrs
Interest expense	`InterestExpense`	$163.32K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-5.34K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-164.06K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-163.32K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-10.54K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-458.30K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-184.60K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-567.88K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-192.31K	USD	2 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	23.11M	shares	2 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	26.45M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	67.19M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	67.19M	shares	2 Qtrs
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.00	USD	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.02	USD	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.02	USD	2 Qtrs
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.00	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-458.30K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-184.60K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-567.88K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-192.31K	USD	2 Qtrs
Currency translation losses	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$61.00	USD	2 Qtrs
Currency translation losses	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-4.66K	USD	1 Quarter
Currency translation losses	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$6.58K	USD	1 Quarter
Currency translation losses	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-17.95K	USD	2 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-585.83K	USD	2 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-178.02K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-192.25K	USD	2 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-462.96K	USD	1 Quarter

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-458.30K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-184.60K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-567.88K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-192.31K	USD	2 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	2 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$460.12K	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-162.36K	USD	2 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	2 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-3.68K	USD	2 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$93.92K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$554.04K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$158.67K	USD	2 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-33.64K	USD	2 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.84K	USD	2 Qtrs
Issuance of stock for cash	`ProceedsFromIssuanceOfCommonStock`	$8.00K	USD	2 Qtrs
Issuance of stock for cash	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	2 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$-518.00	USD	2 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	-	USD	2 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	-	USD	2 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$7.18K	USD	2 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$28.60K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$28.60K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$14.66K	USD	2 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$5.18K	USD	2 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-807.00	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$138.00	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$15.00	USD	2 Qtrs
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$82.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$48.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$33.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$220.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$82.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$48.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$33.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$220.00	USD	Point-in-time
Conversion of notes payable to common stock	`DebtConversionOriginalDebtAmount3`	$10.00K	USD	2 Qtrs
Conversion of notes payable to common stock	`DebtConversionOriginalDebtAmount3`	-	USD	2 Qtrs
Conversion of liability to common stock	`StockIssued1`	$39.92K	USD	2 Qtrs
Conversion of liability to common stock	`StockIssued1`	$41.50K	USD	2 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	-	USD	2 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	-	USD	2 Qtrs
Conversion of accounts payable to equity (Note 7)	`DebtConversionOriginalDebtAmount2`	$217.81K	USD	2 Qtrs
Conversion of accounts payable to equity (Note 7)	`DebtConversionOriginalDebtAmount2`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.